Seraxis
PrivateLast Round
Grant
Jun 14, 2024
Total Funding Raised
$48.1M
Momentum Score
50 /100
Company Overview
Seraxis is a biotechnology company specializing in cell replacement therapies that aim to provide a long-term cure for insulin-dependent diabetes by producing insulin to regulate glucose levels without requiring immune suppression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Seraxis Comps
Public and private peers based on sector, stage, and business model.
Seraxis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 14, 2024 | ||||
| Grant | May 14, 2024 | ||||
| VC Round | Sep 21, 2023 | ||||
| Series C | Feb 9, 2021 | ||||
| Grant | May 11, 2017 | ||||
Series B | Aug 10, 2016 |
Seraxis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Frazier Healthcare Partners | Series C |
| ASAP Ventures | Series A |
| Frazier Life Sciences | Series C, VC Round |
| East West Capital Partners | Series A |
| JDRF | Series C, VC Round |
| T1D Fund | Series C, VC Round |
| Maryland Stem Cell Research Fund | Grant |
Seraxis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Seraxis's valuation, stock price, and market status.
